Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer

Stopped early · Not applicable

Conditions studied: Prostate Cancer

In brief

RATIONALE: Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This trial is studying the side effects of stereotactic radiation therapy and to see how well it works in treating patients with prostate cancer.

Key facts

Study ID

NCT00619515

Run by

Case Comprehensive Cancer Center

People needed

73

Starts

2007-12-01

Expected to finish

2013-02-01

Last updated by the study team

2019-08-22

Who can join

Age: any, up to 120. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center — Cleveland, Ohio, United States
• University Suburban Health Center — Cleveland, Ohio, United States
• UHHS Chagrin Highlands Medical Center — Cleveland, Ohio, United States
• UH-Westlake — Westlake, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.